These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23318260)

  • 1. Chd5 requires PHD-mediated histone 3 binding for tumor suppression.
    Paul S; Kuo A; Schalch T; Vogel H; Joshua-Tor L; McCombie WR; Gozani O; Hammell M; Mills AA
    Cell Rep; 2013 Jan; 3(1):92-102. PubMed ID: 23318260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalent recognition of histone tails by the PHD fingers of CHD5.
    Oliver SS; Musselman CA; Srinivasan R; Svaren JP; Kutateladze TG; Denu JM
    Biochemistry; 2012 Aug; 51(33):6534-44. PubMed ID: 22834704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.
    Wu X; Zhu Z; Li W; Fu X; Su D; Fu L; Zhang Z; Luo A; Sun X; Fu L; Dong JT
    Breast Cancer Res; 2012 May; 14(3):R73. PubMed ID: 22569290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CHD5 in human cancers: 10 years later.
    Kolla V; Zhuang T; Higashi M; Naraparaju K; Brodeur GM
    Cancer Res; 2014 Feb; 74(3):652-8. PubMed ID: 24419087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2.
    Peña PV; Davrazou F; Shi X; Walter KL; Verkhusha VV; Gozani O; Zhao R; Kutateladze TG
    Nature; 2006 Jul; 442(7098):100-3. PubMed ID: 16728977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
    Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
    J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications.
    Musselman CA; Mansfield RE; Garske AL; Davrazou F; Kwan AH; Oliver SS; O'Leary H; Denu JM; Mackay JP; Kutateladze TG
    Biochem J; 2009 Sep; 423(2):179-87. PubMed ID: 19624289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.
    Quan J; Adelmant G; Marto JA; Look AT; Yusufzai T
    PLoS One; 2014; 9(9):e108066. PubMed ID: 25247294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
    Thompson PM; Gotoh T; Kok M; White PS; Brodeur GM
    Oncogene; 2003 Feb; 22(7):1002-11. PubMed ID: 12592387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping.
    Quan J; Yusufzai T
    J Biol Chem; 2014 Jul; 289(30):20717-26. PubMed ID: 24923445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor.
    Peña PV; Hom RA; Hung T; Lin H; Kuo AJ; Wong RP; Subach OM; Champagne KS; Zhao R; Verkhusha VV; Li G; Gozani O; Kutateladze TG
    J Mol Biol; 2008 Jul; 380(2):303-12. PubMed ID: 18533182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
    Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
    Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chd5 orchestrates chromatin remodelling during sperm development.
    Li W; Wu J; Kim SY; Zhao M; Hearn SA; Zhang MQ; Meistrich ML; Mills AA
    Nat Commun; 2014 May; 5():3812. PubMed ID: 24818823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.
    Cai C; Ashktorab H; Pang X; Zhao Y; Sha W; Liu Y; Gu X
    PLoS One; 2012; 7(1):e29750. PubMed ID: 22235338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromodomain Helicase DNA-Binding Protein 5 Inhibits Renal Cell Carcinoma Tumorigenesis by Activation of the p53 and RB Pathways.
    Huang S; Yan Q; Xiong S; Peng Y; Zhao R; Liu C
    Biomed Res Int; 2020; 2020():5425612. PubMed ID: 33062682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer.
    Gorringe KL; Choong DY; Williams LH; Ramakrishna M; Sridhar A; Qiu W; Bearfoot JL; Campbell IG
    Neoplasia; 2008 Nov; 10(11):1253-8. PubMed ID: 18953434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of CHD5 Inactivation in neuroblastomas.
    Koyama H; Zhuang T; Light JE; Kolla V; Higashi M; McGrady PW; London WB; Brodeur GM
    Clin Cancer Res; 2012 Mar; 18(6):1588-97. PubMed ID: 22294723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.
    Wang GG; Song J; Wang Z; Dormann HL; Casadio F; Li H; Luo JL; Patel DJ; Allis CD
    Nature; 2009 Jun; 459(7248):847-51. PubMed ID: 19430464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chd5 Regulates MuERV-L/MERVL Expression in Mouse Embryonic Stem Cells Via H3K27me3 Modification and Histone H3.1/H3.2.
    Hayashi M; Maehara K; Harada A; Semba Y; Kudo K; Takahashi H; Oki S; Meno C; Ichiyanagi K; Akashi K; Ohkawa Y
    J Cell Biochem; 2016 Mar; 117(3):780-92. PubMed ID: 26359639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.
    Zhao R; Yan Q; Lv J; Huang H; Zheng W; Zhang B; Ma W
    Lung Cancer; 2012 Jun; 76(3):324-31. PubMed ID: 22186629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.